FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100477197> ?p ?o ?g. }

• W3100477197 endingPage "3464" @default.
• W3100477197 startingPage "3464" @default.
• W3100477197 abstract "IL3RA (CD123) is the alpha subunit of the interleukin 3 (IL-3) receptor, which regulates the proliferation, survival, and differentiation of hematopoietic cells. IL3RA is frequently expressed in acute myeloid leukemia (AML) and classical Hodgkin lymphoma (HL), presenting an opportunity to treat AML and HL with an IL3RA-directed antibody–drug conjugate (ADC). Here, we describe BAY-943 (IL3RA-ADC), a novel IL3RA-targeting ADC consisting of a humanized anti-IL3RA antibody conjugated to a potent proprietary kinesin spindle protein inhibitor (KSPi). In vitro, IL3RA-ADC showed potent and selective antiproliferative efficacy in a panel of IL3RA-expressing AML and HL cell lines. In vivo, IL3RA-ADC improved survival and reduced tumor burden in IL3RA-positive human AML cell line-derived (MOLM-13 and MV-4-11) as well as in patient-derived xenograft (PDX) models (AM7577 and AML11655) in mice. Furthermore, IL3RA-ADC induced complete tumor remission in 12 out of 13 mice in an IL3RA-positive HL cell line-derived xenograft model (HDLM-2). IL3RA-ADC was well-tolerated and showed no signs of thrombocytopenia, neutropenia, or liver toxicity in rats, or in cynomolgus monkeys when dosed up to 20 mg/kg. Overall, the preclinical results support the further development of BAY-943 as an innovative approach for the treatment of IL3RA-positive hematologic malignancies." @default.
• W3100477197 created "2020-11-23" @default.
• W3100477197 creator A5007299835 @default.
• W3100477197 creator A5008538262 @default.
• W3100477197 creator A5009359386 @default.
• W3100477197 creator A5010301448 @default.
• W3100477197 creator A5013154741 @default.
• W3100477197 creator A5020518251 @default.
• W3100477197 creator A5020982502 @default.
• W3100477197 creator A5026172424 @default.
• W3100477197 creator A5040976235 @default.
• W3100477197 creator A5044176437 @default.
• W3100477197 creator A5064749364 @default.
• W3100477197 creator A5073224267 @default.
• W3100477197 creator A5075150391 @default.
• W3100477197 creator A5078920724 @default.
• W3100477197 creator A5087387263 @default.
• W3100477197 date "2020-11-20" @default.
• W3100477197 modified "2023-10-05" @default.
• W3100477197 title "IL3RA-Targeting Antibody–Drug Conjugate BAY-943 with a Kinesin Spindle Protein Inhibitor Payload Shows Efficacy in Preclinical Models of Hematologic Malignancies" @default.
• W3100477197 cites W1488031700 @default.
• W3100477197 cites W1509421652 @default.
• W3100477197 cites W1557597605 @default.
• W3100477197 cites W1795089629 @default.
• W3100477197 cites W1819974901 @default.
• W3100477197 cites W1966680971 @default.
• W3100477197 cites W1983782677 @default.
• W3100477197 cites W1995904882 @default.
• W3100477197 cites W1999184952 @default.
• W3100477197 cites W2001479776 @default.
• W3100477197 cites W2008748351 @default.
• W3100477197 cites W2010009559 @default.
• W3100477197 cites W2016190362 @default.
• W3100477197 cites W2029178312 @default.
• W3100477197 cites W2033560619 @default.
• W3100477197 cites W2050937173 @default.
• W3100477197 cites W2056605370 @default.
• W3100477197 cites W2070387456 @default.
• W3100477197 cites W2087762900 @default.
• W3100477197 cites W2115492737 @default.
• W3100477197 cites W2125306062 @default.
• W3100477197 cites W2146300845 @default.
• W3100477197 cites W2150046006 @default.
• W3100477197 cites W2164757104 @default.
• W3100477197 cites W2165392081 @default.
• W3100477197 cites W2282129010 @default.
• W3100477197 cites W2299463172 @default.
• W3100477197 cites W2315322079 @default.
• W3100477197 cites W2324763171 @default.
• W3100477197 cites W2411745199 @default.
• W3100477197 cites W2552830230 @default.
• W3100477197 cites W2585106732 @default.
• W3100477197 cites W2597045666 @default.
• W3100477197 cites W2620723923 @default.
• W3100477197 cites W2746429831 @default.
• W3100477197 cites W2761653596 @default.
• W3100477197 cites W2768799228 @default.
• W3100477197 cites W2800912743 @default.
• W3100477197 cites W2891142726 @default.
• W3100477197 cites W2898159047 @default.
• W3100477197 cites W2903930842 @default.
• W3100477197 cites W2913410729 @default.
• W3100477197 cites W2921244588 @default.
• W3100477197 cites W2921589168 @default.
• W3100477197 cites W2972339682 @default.
• W3100477197 cites W3013670789 @default.
• W3100477197 cites W3042968239 @default.
• W3100477197 cites W4211057725 @default.
• W3100477197 cites W973996432 @default.
• W3100477197 doi "https://doi.org/10.3390/cancers12113464" @default.
• W3100477197 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7709048" @default.
• W3100477197 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33233768" @default.
• W3100477197 hasPublicationYear "2020" @default.
• W3100477197 type Work @default.
• W3100477197 sameAs 3100477197 @default.
• W3100477197 citedByCount "9" @default.
• W3100477197 countsByYear W31004771972021 @default.
• W3100477197 countsByYear W31004771972022 @default.
• W3100477197 countsByYear W31004771972023 @default.
• W3100477197 crossrefType "journal-article" @default.
• W3100477197 hasAuthorship W3100477197A5007299835 @default.
• W3100477197 hasAuthorship W3100477197A5008538262 @default.
• W3100477197 hasAuthorship W3100477197A5009359386 @default.
• W3100477197 hasAuthorship W3100477197A5010301448 @default.
• W3100477197 hasAuthorship W3100477197A5013154741 @default.
• W3100477197 hasAuthorship W3100477197A5020518251 @default.
• W3100477197 hasAuthorship W3100477197A5020982502 @default.
• W3100477197 hasAuthorship W3100477197A5026172424 @default.
• W3100477197 hasAuthorship W3100477197A5040976235 @default.
• W3100477197 hasAuthorship W3100477197A5044176437 @default.
• W3100477197 hasAuthorship W3100477197A5064749364 @default.
• W3100477197 hasAuthorship W3100477197A5073224267 @default.
• W3100477197 hasAuthorship W3100477197A5075150391 @default.
• W3100477197 hasAuthorship W3100477197A5078920724 @default.
• W3100477197 hasAuthorship W3100477197A5087387263 @default.
• W3100477197 hasBestOaLocation W31004771971 @default.
• W3100477197 hasConcept C126322002 @default.
• W3100477197 hasConcept C159654299 @default.

• next